The drug development funding playbook that worked for decades is now in trouble, University of Pennsylvania Perelman School ...

European life sciences investor Medicxi has raised 500 million euros (about $581.6 million) to go directly toward innovative ...

Jonathan Faison, leader of Seeking Alpha’s ROTY Biotech Community, shares how he uses the platform’s tools - from news, ...

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the regionThe Asia ...

Tracking insider buying and selling can provide valuable insights for investors. When company executives, directors, or major shareholders invest their own money in their company’s stock, it may ...

Repligen (RGEN) is a top bioprocessing stock pick for long-term investors. It has strong balance sheet and recurring organic ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

With that as a backdrop, let's consider two companies in the biotech industry that could make steady progress in the next few ...

Learn more about whether Legend Biotech Corporation or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The EU Biotech Act was first spoken about in EC President Ursula von der Leyen's political guidelines for 2025 in July 2024.

At a recent lunch in Melbourne, two dozen luminaries exchanged war stories about their two decades-plus involvement in the ...

Regeneron Pharmaceuticals, a global biotech company founded in New York City, is more than doubling its manufacturing ...